Investing RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202 by admin June 4, 2025 June 4, 2025 Radiopharm Theranostics (RAD:AU) has announced RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202 Download the PDF here. This post appeared first on investingnews.com previous post 5 Biggest Blockchain ETFs in 2025 next post Adam Rozencwajg: Gold Stock Gains, Silver and Uranium Prices — Plus PGMs Bull Case You may also like Rare Earths Firm MP Materials to Get US$400... July 14, 2025 Exceptional result of 32m @ 7gt Au in... September 10, 2025 Providence Gold Mines Inc. Options La Dama de... August 21, 2025 IAMGOLD Expands Québec Footprint via Acquisition of Northern... October 22, 2025 How to Invest in Vanadium Stocks September 18, 2025 Biotech and Pharma Market Update: Q2 2025 in... July 25, 2025 The True Value of Olympic Gold: Beyond Metal... February 13, 2026 Rae Copper Project delivers further high-grade mineralisation with... May 13, 2025 Clem Chambers: Silver Can “Easily” Hit US$100, Retail... December 9, 2025 OPINION — Goldenomics 101: Follow the Money July 19, 2025